- Thermo Fisher Scientific (TMO.US) shares are up about 4% in premarket trading today following the announcement of a strategic collaboration with OpenAI.
- This is yet another example of a company outside the traditional technology sector announcing a partnership with OpenAI in an effort to be seen by investors as a beneficiary of the AI revolution.
- Thermo Fisher Scientific (TMO.US) shares are up about 4% in premarket trading today following the announcement of a strategic collaboration with OpenAI.
- This is yet another example of a company outside the traditional technology sector announcing a partnership with OpenAI in an effort to be seen by investors as a beneficiary of the AI revolution.
Thermo Fisher Scientific (TMO.US) shares are up about 4% in premarket trading today following the announcement of a strategic collaboration with OpenAI. The company is implementing artificial intelligence solutions in key areas of its business, from clinical research and customer service to the Accelerator™ Drug Development platform and internal ChatGPT Enterprise implementations, with the aim of reducing the time to market for new drugs, managing innovation more effectively, and making better use of resources.
This is another example of a company outside the traditional technology sector announcing a partnership with OpenAI in an effort to be seen by investors as a beneficiary of the AI revolution that is driving the valuations of giants such as Nvidia, Microsoft, and Alphabet. The market clearly rewards any attempts to implement AI-based solutions: there is an automatic narrative about the possibility of repeating the success of technology companies whose shares have been gaining for months thanks to the AI boom. Hence today's positive reaction to TMO's stock price – investors see an opportunity for other sectors to jump on the fast-moving AI technology bandwagon, seeking to replicate the success of companies that have been key beneficiaries of this transformation for some time.
Just before the opening of Wall Street, the company's shares are up 4% and testing the recent local highs from October.
Source: xStation
Stock of the Week - Lam Research Corp (16.10.2025)
Salesforce surges 8% amid positive long-term revenue forecast📈
DE40: Europe moves sideways, Nestle gains
Nestlé: Steady Growth and Ambitious Restructuring Drive Share Price Surge
This content has been created by XTB S.A. This service is provided by XTB S.A., with its registered office in Warsaw, at Prosta 67, 00-838 Warsaw, Poland, entered in the register of entrepreneurs of the National Court Register (Krajowy Rejestr Sądowy) conducted by District Court for the Capital City of Warsaw, XII Commercial Division of the National Court Register under KRS number 0000217580, REGON number 015803782 and Tax Identification Number (NIP) 527-24-43-955, with the fully paid up share capital in the amount of PLN 5.869.181,75. XTB S.A. conducts brokerage activities on the basis of the license granted by Polish Securities and Exchange Commission on 8th November 2005 No. DDM-M-4021-57-1/2005 and is supervised by Polish Supervision Authority.
